Effects of Depletion of Leukocytes and Platelets on Cardiac Dysfunction After Cardiopulmonary Bypass Yukio Chiba, Kouichi Morioka, Ryusuke Muraoka, Akio.

Slides:

Advertisements

Similar presentations

Relative Changes in Cerebral Blood Flow During Cardiac Operations Using Xenon-133 Clearance Versus Transcranial Doppler Sonography Uday H Trivedi, FRCS,

Advertisements

Stress-Dose Corticosteroid Versus Placebo in Neonatal Cardiac Operations: A Randomized Controlled Trial Pertti K. Suominen, MD, PhD, Juho Keski-Nisula,

Assessment of Cerebral Blood Flow With Transcranial Doppler in Right Brachial Artery Perfusion Patients Ümit Karadeniz, MD, Özcan Erdemli, MD, Mehmet.

Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia Abdellah Aouifi, MD, Pascale Blanc, MD, Vincent.

Changes in cysteinyl leukotrienes during and after cardiac surgery with cardiopulmonary bypass in patients with and without chronic obstructive pulmonary.

Yuji Hiramatsu, MDa, Nicolas Gikakis, BSEa, Harry L

Sally Bannan, Amanda Danby, Dahlia Cowan, Saeed Ashraf, Paul G Martin

Reduction of the Inflammatory Response in Patients Undergoing Minimally Invasive Coronary Artery Bypass Grafting Y.John Gu, Massimo A Mariani, Willem.

The Myocardial Protective Effects of a Moderate-Potassium Blood Cardioplegia in Pediatric Cardiac Surgery: A Randomized Controlled Trial Yang Liu, MD,

Coronary Artery Bypass Grafting in Immune Thrombocytopenic Purpura

Attenuation of Changes in Leukocyte Surface Markers and Complement Activation With Heparin-Coated Cardiopulmonary Bypass Oddvar Moen, MD, Kolbjørn Høgåsen,

Kai Ihnken, MD, Kiyozo Morita, MD, Gerald D Buckberg, MD

Preoperative Detection of Pleural Adhesions by Chest Ultrasonography

Relative Changes in Cerebral Blood Flow During Cardiac Operations Using Xenon-133 Clearance Versus Transcranial Doppler Sonography Uday H Trivedi, FRCS,

A Closed Perfusion System With Heparin Coating and Centrifugal Pump Improves Cardiopulmonary Bypass Biocompatibility in Elderly Patients Lena Lindholm,

Effect of l-arginine or nitroglycerine during deep hypothermic circulatory arrest in neonatal lambs Shinichi Hatsuoka, MD, Takahiko Sakamoto, MD, Ulrich.

P. W. Boonstra, MD, PhD, Y. J. Gu, MD, PhD, C. Akkerman, BSc, J

Tumor Angiogenesis as a Prognostic Marker in Operable Non–Small Cell Lung Cancer Katsuhiko Matsuyama, Yukio Chiba, Masato Sasaki, Hirokazu Tanaka, Ryusuke.

Continuous pulmonary perfusion during cardiopulmonary bypass prevents lung injury in infants Takaaki Suzuki, MD, Toyoki Fukuda, MD, Tsutomu Ito, MD,

James L Zellner, MD, Scott B Kribbs, BS, B

Bashir M Matata, PhD, Andrzej W Sosnowski, MD, Manuel Galiñanes

Giant mediastinal bronchial artery aneurysm mimicking benign esophageal tumor: a case report and review of 26 cases from literature Kuniyoshi Tanaka,

Assessment of heparin anticoagulation: comparison of two commercially available methods Hanne I Flom-Halvorsen, PhD, Eivind Øvrum, MD, PhD, Michel Abdelnoor,

Aprotinin and Dipyridamole for the Safe Reduction of Postoperative Blood Loss Gideon Cohen, Joan Ivanov, Richard D Weisel, Vivek Rao, Molly K Mohabeer,

Leukocyte depletion during cardiac operation: a new approach through the venous bypass circuit Y.John Gu, MD, PhD, A.J de Vries, MD, Paulien Vos, Piet.

Emergency Coronary Artery Bypass Grafting Can Be Performed Safely Without Cardiopulmonary Bypass in Selected Patients Faraz Kerendi, MD, John D. Puskas,

Aprotinin in pediatric cardiac operations: a benefit in complex malformations and with high-dose regimen only Thierry P Carrel, MD, Mike Schwanda, MD,

Magnesium-supplemented warm blood cardioplegia in patients undergoing coronary artery revascularization Mark Yeatman, Massimo Caputo, MD, Pradeep Narayan,

Susanne Lison, MD, Michael Spannagl, MD, PhD, Wulf Dietrich, MD, PhD

Detrimental Effects of Cardiopulmonary Bypass in Cyanotic Infants: Preventing the Reoxygenation Injury Bradley S. Allen, MD, Shaikh Rahman, MS, Michel.

The influence of leukocyte filtration during cardiopulmonary bypass on postoperative lung function: A clinical study Tomislav Mihaljevic, MDa, Martin.

Synergistic Immunosuppression Caused by High-Dose Methylprednisolone and Cardiopulmonary Bypass Hisanori Mayumi, MD, Qui-Wei Zhang, MD, Atsuhiro Nakashima,

Comparison of bovine and porcine heparin in heparin antibody formation after cardiac surgery John L Francis, PhD, George J Palmer, MD, Rebecca Moroose,

The effects of heparin and extracorporeal circulation on platelet counts and platelet microaggregation during cardiopulmonary bypass Elijah W. Muriithi,

Comparative effects of propofol versus fentanyl on cerebral oxygenation state during normothermic cardiopulmonary bypass and postoperative cognitive dysfunction

Stress-Dose Corticosteroid Versus Placebo in Neonatal Cardiac Operations: A Randomized Controlled Trial Pertti K. Suominen, MD, PhD, Juho Keski-Nisula,

Changes in cysteinyl leukotrienes during and after cardiac surgery with cardiopulmonary bypass in patients with and without chronic obstructive pulmonary.

Clinical performance and biocompatibility of poly(2-methoxyethylacrylate)—coated extracorporeal circuits Serdar Gunaydin, MD, Bora Farsak, MD, Mustafa.

Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia Abdellah Aouifi, MD, Pascale Blanc, MD, Vincent.

Anne H Kuitunen, MD, Lasse J Heikkilä, MD, Markku T Salmenperä, MD

Long-term results of reoperative mitral valve surgery in patients with rheumatic disease Katsuhiko Matsuyama, MD, Masahiko Matsumoto, MD, Takaaki Sugita,

Coronary surgery without cardiotomy suction and autotransfusion reduces the postoperative systemic inflammatory response Martin Westerberg, MD, Anders.

Effects of perfusion mode on regional and global organ blood flow in a neonatal piglet model Akif Ündar, PhD, Takafumi Masai, MD, Shuang-Qiang Yang,

Benjamin C. Sun, MD, Timothy A. Dickinson, CCP, Eric A

Which is better to preserve pulmonary function: Short-term or prolonged leukocyte depletion during cardiopulmonary bypass? Kaiyu Tao, MD, Qi An, MD,

Editorial Board, January 2010

Bradford B. Smith, MD, Matthew A

Anticoagulation with bivalirudin during cardiopulmonary bypass in cardiac surgery Julio C Vasquez, MD, Anna Vichiendilokkul, PharmD, Syed Mahmood, MD,

Platelet and Neutrophil Activation During Cardiac Surgical Procedures: Impact of Cardiopulmonary Bypass David S Morse, David Adams, Barbarajean Magnani

Individualized heparin and protamine management in infants and children undergoing cardiac operations Massimiliano Codispoti, MD, Christopher A Ludlam,

Completely Thrombosed Tricuspid Pouch Mimicking a Cardiac Tumor

Drew-Anderson technique attenuates systemic inflammatory response syndrome and improves respiratory function after coronary artery bypass grafting Josef.

Inhibitory effect of milrinone on cytokine production after cardiopulmonary bypass Nobuhiko Hayashida, MD, PhD, Hiroshi Tomoeda, MD, Takeshi Oda, MD,

Inflammatory Mediators in Adults Undergoing Cardiopulmonary Bypass: Comparison of Centrifugal and Roller Pumps Saeed Ashraf, John Butler, Yi Tian, Dahlia.

Time course of proinflammatory and anti-inflammatory responses after cardiac operation: monocyte HLA-DR expression Y.John Gu, MD, PhD, Willem van Oeveren,

Effect of cardiopulmonary bypass on pulmonary gas exchange: a prospective randomized study Craig M Cox, Raimondo Ascione, MD, Alan M Cohen, Ian M Davies,

Association of bacterial infection and red blood cell transfusion after coronary artery bypass surgery Scott B Chelemer, MD, B.Stephen Prato, MA, Paul.

Use of recombinant factor VIIa as a rescue treatment for intractable bleeding following repeat aortic arch repair Greg Stratmann, MD, PhD, Isobel A Russell,

Aprotinin Enhances the Endogenous Release of Interleukin-10 After Cardiac Operations Gary E Hill, Robert P Diego, Alfred H Stammers, Suzanne M Huffman,

Sunil K. Ohri, Christopher W. Bowles, Robert T. Mathie, David R

Effect of Nitric Oxide Gas on Platelets During Open Heart Operations

Joachim Boldt, Bernd Kumle, Michael Papsdorf, Gunter Hempelmann

Successful use of argatroban as a heparin substitute during cardiopulmonary bypass: heparin-induced thrombocytopenia in a high-risk cardiac surgical patient

Increased neutrophil priming and sensitization before commencing cardiopulmonary bypass in cardiac surgical patients Y.John Gu, MD, PhD, Pieter Schoen,

The Impact of New Technology on Cardiothoracic Surgical Practice

Influence of High- and Low-Dose Aprotinin on Activation of Hemostasis in Open Heart Operations Wulf Dietrich, Karl Schöpf, Michael Spannagl, Marianne.

Karl A. Bocchieri, BS, CCP, S. Jacob Scheinerman, MD, L

Safety of low hematocrits during cardiopulmonary bypass

Y.John Gu, MD, PhD, Piet W. Boonstra, MD, PhD, Willem van Oeveren, PhD

A randomized trial of antithrombin concentrate for treatment of heparin resistance Mathew R Williams, MD, Alyssa B D’Ambra, BA, James R Beck, Talia B.

Presentation transcript:

Effects of Depletion of Leukocytes and Platelets on Cardiac Dysfunction After Cardiopulmonary Bypass Yukio Chiba, Kouichi Morioka, Ryusuke Muraoka, Akio Ihaya, Tetsuya Kimura, Takahiko Uesaka, Takeshi Tsuda, Katsuhiko Matsuyama The Annals of Thoracic Surgery Volume 65, Issue 1, Pages 107-113 (January 1998) DOI: 10.1016/S0003-4975(97)01111-9

Fig. 1 Leukocyte counts and platelet counts before, during, and after cardiopulmonary bypass (CPB) in the LPD group (closed circles) and the control group (open circles). (WBC = white blood cell; ∗p < 0.05 versus the LPD group; ∗∗∗p < 0.005 versus the LPD group.) The Annals of Thoracic Surgery 1998 65, 107-113DOI: (10.1016/S0003-4975(97)01111-9)

Fig. 2 The plasma concentration of leukocyte elastase before, during, and after cardiopulmonary bypass (CPB) in the LPD group (closed circles) and the control group (open circles). (∗p < 0.05 versus the LPD group.) The Annals of Thoracic Surgery 1998 65, 107-113DOI: (10.1016/S0003-4975(97)01111-9)